Abstract
This study was carried out to assess the personality changes of marijuana users and to examine whether marijuana users are prone to psychotic or neurotic features. Purposive sampling method was used for collecting the data. 16 PF and E.P.Q.-R were administered for assessing the personality changes and to detect the development of psychotic and neurotic features for both the groups. The mental condition of the normal individual was worked out by using the General Health Questionnaire 12 items. All the subjects were male because female marijuana users were not available during study period. The study shows that there is difference between the two groups by the primary factors on factor E (Humble vs. Assertive) and M (Practical vs. Imaginative). But there is no difference in Global factors between the two groups. On factor E (Humble vs. Assertive) user tend to accommodate others wishes, and are cooperative and agreeable, willing to set aside their own wishes and feelings. On factor M (Practical vs. Imaginative) users are more oriented to abstract ideas than the external facts practicalities. Being focused on thinking, imagination and fantasy, high scorers generate many ideas and theories and often creative. Extreme scorers can be so absorbed in thought that they can be absentminded and impractical. Highest percentage in extraversion for the control group and highest percentage in neurotic for the case group were found in assessment of three dimensions-psychotic, extraversion and neurotic according to E.P.Q.-R. Extraversion as opposed to introversion, refers to the outgoing, uninhibited, sociable proclivities of a person whereas, Neuroticism refers to the general emotional liability of a person, his emotional over -responsiveness and his liability to neurotic breakdown under stress. Severe and prolong case of neuroticism may lead to the development of psychotic illness in the later stage of life.
Keywords: Marijuana, 16 PF, E.P.Q-R, GHQ.
References
- Williams. Keywords: A vocabulary of culture and society 1976; London:
Fontana
- Haslam. Introduction to Personality and Intelligence.2007 Sage Publications Ltd.1-12.
- Tauwn. The religions and medicinal uses of cannabis in China, India and Tibet: J Psychoactive Drugs1981; 13(1):23- 4
- Mechoulam. "Isolation, structure and partial synthesis of an active constituent of hashish" (PDF). Journal of the American Chemical Society 1964 86 (8): 16(Bolla, et al, 2002).–1647.
- I. Kaplan, M.D. and B. J. Sadock, M.D. Cannabis related Disorders: Benjamin James Sadock and Virginia Alcott Sadock, editors; Synopsis of psychiatry.10th Ed. New Delhi: Wolters Kluwer Pvt Ltd;
2007. p. 417-21.
- I. Kaplan, M.D., and B. J. Sadock, M.D. Synopsis of Psychiatry: Behavioral
Sciences/Clinical Psychiatry. 8th edition. Baltimore, MD: Lippincott Williams and Wilkins 1998.
- E. Joy, S. J. Jr, Watson and J.A. Jr, Benson. Marijuana and medicine:
assessing the science base” Division of Neuroscience and behavioral health, Institute of Medicine1999; 39-52.
- T. Sheldon. Review shows that cannabis use is a risk factor for schizophrenia. BMJ 2003; 327:1070.
- Dughiero , F Schifano ,G Forza , Personality dimensions and
psychopathological profiles of ecstasy users. Hum Psychopharmacol 2001; 16(8):635- 9.
- Chabrol, J.D Mabila , E. Chauchard , Influence of Cannabis use on
suicidal ideations among 491 high-school students. Encephale 2008; 34(3):270-73.
- Jr.William. The Marijuana a motivational Syndrome: A review of the
research by Slikker 2008.
- American Psychiatric Association, Diagnostic and statistical manual of mental disorders. 4thEd. New Delhi: Jaypee; 1995.
- P Goldberg, Manual of GHQ-28: Psychological Medicine 1997; 27: 191- 7
- B Cattell, H.W Eher and Tatswake, Institute of Personality and Ability
testing: Handbook for the 16 PF Questionnaire (16PF) 1970.
- Eysenck and Eysenck, Manual of Eysenck’s Personality Questionnaire-(EPQ-R): ‘Psychoticism: A Dimension of Personality’1975.
- M. Moore Theresa, Z. Stanley, L.H. Anne et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. The Lancet 2008; 370(9584):319-28.
Corresponding Author
Dr Koijam Shantibala Devi
Email: This email address is being protected from spambots. You need JavaScript enabled to view it., #+91-9862578722
DOI: https://dx.doi.org/10.18535/jmscr/v6i7.79
